OMI logo

Owens & Minor (OMI)

Profile

Full Name

Owens & Minor, Inc.

Ticker Symbol

OMI

Exchange

NYSE

Sector

Healthcare

Industry

Medical Distribution

Country

United States

IPO

March 17, 1980

Indexes

Not included

Website

http://www.owens-minor.com

Employees

23200

Key Details

Price

$6.77(+1.80%)

Market cap

$522.96M(Small cap)

Last Dividend

$0.00

TTM Dividend yield

-

Annual revenue

$10.70B(+3.55% YoY)

Annual EPS

-$4.73(-775.93% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.77
OMI price is $6.77

30-Day Relative Volume

1.14
OMI 30-day relative volume is 1.14

Price Performance

Price Most recent change

+1.8%
OMI price was up +1.8% on Apr 16, 2025

Price YTD change

-48.2%
OMI price is down -48.2% since January 1st

Price 1-year change

-72.76%
OMI price is down -72.76% year-on-year

Price 3-year change

-84.49%
OMI price is down -84.49% over the past 3 years

Price Range

Price All-time high

$49.16
OMI price is currently -86.23% below its historical high of $49.16

Price 3-year low

$6.07
OMI price is currently +11.53% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$522.96M
OMI market capitalization is $522.96 million

Market cap 3-year change

-84.25%
OMI market capitalization is down -84.25% over the past 3 years

Market cap All-time high

$3.66B
OMI market capitalization is currently -85.72% below its historical high of $3.66 billion

Market cap sector rank

70.15%
OMI market capitalization is higher than 70.15% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.04%
OMI shares outstanding is up +1.04% year-on-year

Shares Outstanding 3-Year Change

+1.53%
OMI shares outstanding is up +1.53% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.84
OMI beta is 0.84

200-day SMA

$12.74
OMI price is currently -46.88% below its 200-day simple moving average

50-day SMA

$8.39
OMI price is currently -19.31% below its 50-day simple moving average

RSI

29.04
OMI 14-day relative strength index is 29.04

Volume

1.14
OMI 30-day relative volume is 1.14

ATR

$0.60
OMI average true range is $0.60

10-day Historical Volatility

44.58%
OMI 10-day historical volatility is 44.58%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.00
OMI last dividend was $0.00 per share, with an ex-dividend date of December 14, 2021

Next Dividend

-
OMI next dividend has not yet been announced

Dividend per share

Dividend per share

-
OMI annual dividend per share value is unknown

Dividend per share Sector Rank

-
OMI annual dividend per share is unknown

Dividend per share 1-Year Change

-
OMI annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
OMI annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
OMI annual dividend yield value is unknown

Dividend yield Sector Rank

-
OMI annual dividend yield is unknown

Other

Payout ratio

-
OMI annual payout ratio value is unknown

Dividends paid

-
OMI annual dividends paid value is unknown

Free cash flow

-$66.67M
OMI annual free cash flow is -$66.67 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.70B
OMI annual revenue is $10.70 billion

Revenue Analysts estimate

$10.95B
OMI annual revenue is currently -2.28% lower than the consensus analysts' forecast

Revenue 1-year change

+3.55%
OMI annual revenue is up +3.55% year-on-year

Revenue Sector rank

94.51%
OMI annual revenue is higher than 94.51% of companies in Healthcare sector

EPS

EPS

-$4.73
OMI annual earnings per share is -$4.73

EPS Analysts estimate

$1.75
OMI annual earnings per share is currently -370.32% lower than the consensus analysts' forecast

EPS 1-year change

-775.93%
OMI annual earnings per share is down -775.93% year-on-year

EPS Sector rank

20.33%
OMI annual earnings per share is higher than 20.33% of companies in Healthcare sector

Profit

Gross profit

$2.22B
OMI annual gross profit is $2.22 billion

Gross margin

20.74%
OMI annual gross profit margin is 20.74%

Operating profit

$296.05M
OMI annual operating income is $296.05 million

Operating margin

2.77%
OMI annual operating profit margin is 2.77%

Net income

-$362.69M
OMI annual net profit is -$362.69 million

Net margin

-3.39%
OMI annual net profit margin is -3.39%

Expenses

Total expenses

$10.40B
OMI annual total expenses is $10.40 billion

Operating expenses

$1.92B
OMI annual total operating expenses is $1.92 billion

Cost of goods sold

$8.48B
OMI annual cost of goods sold is $8.48 billion

Selling, general & administrative expenses

$1.91B
OMI annual SGA is $1.91 billion

Depreciation and amortization

$264.77M
OMI annual depreciation & amortization is $264.77 million

Interest expense

$143.80M
OMI annual interest expense is $143.80 million

Income tax

$5.33M
OMI annual income tax is $5.33 million

EBIT & EBITDA

EBIT

-$213.55M
OMI annual earnings before interest & taxes is -$213.55 million

EBITDA

$51.22M
OMI annual EBITDA is $51.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.66B
OMI annual total assets is $4.66 billion

Non current assets

$2.63B
OMI annual long term assets is $2.63 billion

Current assets

$2.02B
OMI annual total current assets is $2.02 billion

Cash and cash equivalents

$49.38M
OMI annual cash & cash equivalents is $49.38 million

Accounts receivable

$690.24M
OMI annual accounts receivable is $690.24 million

Inventory

$1.13B
OMI annual inventory is $1.13 billion

Liabilities

Total liabilities

$4.09B
OMI annual total liabilities is $4.09 billion

Long term liabilities

$2.22B
OMI annual total long term liabilities is $2.22 billion

Current liabilities

$1.87B
OMI annual total current liabilities is $1.87 billion

Accounts payable

$1.25B
OMI annual accounts payable is $1.25 billion

Debt

Total debt

$2.14B
OMI annual total debt is $2.14 billion

Total debt 1-year change

-7.76%
OMI annual total debt is down -7.76% year-on-year

Long term debt

$2.09B
OMI annual long term debt is $2.09 billion

Short term debt

$45.20M
OMI annual short term debt is $45.20 million

Equity & Capital

Shareholders equity

$565.23M
OMI annual stockholders equity is $565.23 million

Book value

$565.23M
OMI annual book value is $565.23 million

Retained earnings

$6.02M
OMI annual retained earnings is $6.02 million

Working capital

$147.28M
OMI annual working capital is $147.28 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$161.50M
OMI annual cash flow from operations is $161.50 million

Cash from operations 1-year change

-78.2%
OMI annual cash flow from operations is down -78.2% year-on-year

Cash from investing

-$116.53M
OMI annual cash flow from investing activities is -$116.53 million

Cash from investing 1-year change

+15.1%
OMI annual cash flow from investing activities is up +15.1% year-on-year

Cash from financing

-$267.60M
OMI annual cash flow from financing activities is -$267.60 million

Cash from financing 1-year change

+35.88%
OMI annual cash flow from financing activities is up +35.88% year-on-year

CAPEX

CAPEX

$228.16M
OMI annual capital expenditures is $228.16 million

CAPEX 1-year change

+9.75%
OMI annual capital expenditures is up +9.75% year-on-year

Free Cash Flow

Free cash flow

-$66.67M
OMI annual free cash flow is -$66.67 million

Free cash flow 1-year change

-112.51%
OMI annual free cash flow is down -112.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

20.74%
OMI annual gross profit margin is 20.74%

Operating margin

2.77%
OMI annual operating profit margin is 2.77%

Net margin

-3.39%
OMI annual net profit margin is -3.39%

ROA & ROE

ROA

-7.44%
OMI annual return on assets is -7.44%

ROE

-48.70%
OMI annual return on equity is -48.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OMI price to earnings ratio value is unknown

PE ratio Sector rank

-
OMI price to earnings ratio is unknown

PB Ratio

PB ratio

0.93
OMI price to book ratio is 0.93

PB ratio Sector rank

43.08%
OMI price to book ratio is higher than 43.08% of companies in Healthcare sector

PS Ratio

PS ratio

0.05
OMI price to sales ratio is 0.05

PS ratio Sector rank

3.59%
OMI price to sales ratio is higher than 3.59% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.61B
OMI enterprise value is $2.61 billion

Enterprise value Sector rank

84.39%
OMI enterprise value is higher than 84.39% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

51.02
OMI EV/EBITDA is 51.02

EV/EBITDA Sector rank

97.57%
OMI EV/EBITDA is higher than 97.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.08
OMI annual current ratio is 1.08

Quick ratio

0.47
OMI annual quick ratio is 0.47

Leverage

Debt to equity

3.25
OMI annual debt to equity ratio is 3.25

Interest coverage ratio

-1.49
OMI annual interest coverage ratio is -1.49

Risk & Stability

Piotroski F-Score

5
OMI piotroski f-score is 5

Altman Z-Score

2.26
OMI altman z-score is 2.26

Analyst ratings

Recent major analysts updates

Mar 10, 25 JP Morgan
Underweight
Mar 3, 25 Baird
Neutral
Feb 25, 25 Baird
Neutral
Feb 13, 25 UBS
Buy
Feb 4, 25 Baird
Neutral
Nov 5, 24 UBS
Buy
Nov 5, 24 Citigroup
Buy
Nov 5, 24 Barclays
Equal-Weight
Nov 5, 24 Baird
Neutral
Aug 21, 24 JP Morgan
Underweight

Institutional Ownership

Similar stocks

OPT logo
Opthea Limited (OPT)
ARVN logo
Arvinas (ARVN)
BCYC logo
Bicycle Therapeutics (BCYC)
BVS logo
Bioventus (BVS)
VALN logo
Valneva SE (VALN)
Auna SA (AUNA)
KIDS logo
OrthoPediatrics (KIDS)
Niagen Bioscience (NAGE)
CDXC logo
ChromaDex (CDXC)
  • What is the ticker symbol for Owens & Minor?
  • Does Owens & Minor pay dividends?
  • What sector is Owens & Minor in?
  • What industry is Owens & Minor in?
  • What country is Owens & Minor based in?
  • When did Owens & Minor go public?
  • Is Owens & Minor in the S&P 500?
  • Is Owens & Minor in the NASDAQ 100?
  • Is Owens & Minor in the Dow Jones?
  • When was Owens & Minor's last earnings report?
  • When does Owens & Minor report earnings?
  • Should I buy Owens & Minor stock now?

What is the ticker symbol for Owens & Minor?

The ticker symbol for Owens & Minor is NYSE:OMI

Does Owens & Minor pay dividends?

No, Owens & Minor does not pay dividends

What sector is Owens & Minor in?

Owens & Minor is in the Healthcare sector

What industry is Owens & Minor in?

Owens & Minor is in the Medical Distribution industry

What country is Owens & Minor based in?

Owens & Minor is headquartered in United States

When did Owens & Minor go public?

Owens & Minor's initial public offering (IPO) was on March 17, 1980

Is Owens & Minor in the S&P 500?

No, Owens & Minor is not included in the S&P 500 index

Is Owens & Minor in the NASDAQ 100?

No, Owens & Minor is not included in the NASDAQ 100 index

Is Owens & Minor in the Dow Jones?

No, Owens & Minor is not included in the Dow Jones index

When was Owens & Minor's last earnings report?

Owens & Minor's most recent earnings report was on Feb 28, 2025

When does Owens & Minor report earnings?

The next expected earnings date for Owens & Minor is May 2, 2025

Should I buy Owens & Minor stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page